Melih Yilmaz

Sequence-to-sequence translation from mass spectra to peptides with a transformer model

Melih Yilmaz, William E. Fondrie, Wout Bittremieux et al. · Nature Communications · 2024 · 80 citations · Full text

<i>De novo</i> mass spectrometry peptide sequencing with a transformer model

Melih Yilmaz, William E. Fondrie, Wout Bittremieux et al. · 2022 · 52 citations · Full text

Machine Learning, Biological Mass Spectrometry, Molecular Biology +20

Sequence-to-sequence translation from mass spectra to peptides with a transformer model

Melih Yilmaz, William E. Fondrie, Wout Bittremieux et al. · 2023 · 30 citations · Full text

Peptide Engineering, Biological Mass Spectrometry, Molecular Biology +27

Cetuximab every second week with irinotecan in patients with metastatic colorectal cancer refractory to 5-FU, oxaliplatin, and irinotecan: KRAS mutation status and efficacy.

B. V. Jensen, Jakob Vasehus Schou, Helle Hjorth Johannesen et al. · Journal of Clinical Oncology · 2010 · 10 citations

Cancer Management, Pathology, Kras Tumor Mutation +17

Diverse patient trajectories during cytotoxic chemotherapy: Capturing longitudinal patient‐reported outcomes

Amee D. Azad, Melih Yilmaz, Selen Bozkurt et al. · Cancer Medicine · 2021 · 10 citations · Full text